Exchange: NYSE·Updated 06:13 PM EDT

UNH News

News
all
press releases
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
CNC's improving Medicaid margins, stronger Marketplace profitability and earnings recovery support its valuation, but sustainability remains the key test.
Zacks
Centene's Operations Improve: Does the 12.34X P/E Make it a Buy?
CNC's improving Medicaid margins, stronger Marketplace profitability and earnings recovery support its valuation, but sustainability remains the key test.
Zacks
More News
EQT, UnitedHealth, Clearway Energy And More On CNBC's 'Final Trades'
TV market experts picked GPIQ, UNH, CWEN and EQT; UNH reports Oct. 13, with analysts expecting $4.14 EPS and $111.49B revenue.read more...
Benzinga
Texas AG Targets UnitedHealth: Probe Examines Alleged Bribes, Care Delays and Coverage Denials
Texas AG Ken Paxton is investigating UnitedHealth Group over allegations of illegal care delays, coverage reversals, and Medicare fraud.read more...
Benzinga
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore
UNH heads into Q3 with investors focused on whether medical-cost gains can hold as Medicare Advantage margins improve without deeper member losses.
Zacks
Ensign Builds More Scale as Financial Flexibility Remains Strong
ENSG expands across Florida, Washington and Colorado as strong liquidity and operating cash flow leave room for more acquisitions.
Zacks
Centene Narrows Medicare Advantage Footprint as Costs Remain Elevated
CNC is narrowing its 2027 Medicare Advantage footprint as elevated costs pressure plan economics, with a sharper focus on dual eligibles.
Zacks
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
CVS' Health Care Benefits Arm Shows Better Core Trends: What's Ahead?
CVS Health raises its Health Care Benefits outlook as stronger core trends, led by Medicare, support margin recovery despite medical cost pressures.
Zacks
UNH Exits Select Medicare Advantage Plans for 2027 Amid Cost Pressure
UnitedHealth is exiting select Medicare Advantage plans for 2027 as rising medical costs pressure profitability, reshaping its membership mix.
Zacks
Is It Worth Investing in UnitedHealth (UNH) Based on Wall Street's Bullish Views?
The average brokerage recommendation (ABR) for UnitedHealth (UNH) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks

Advertisement|Remove ads.